Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.3000 (0.41%) ($7.3000 - $7.3000) on Wed. Mar. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.64% (three month average) | RSI | 39 | Latest Price | $7.3000(0.41%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | IOVA declines -1.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(49%) IBB(36%) IWC(29%) ACES(28%) ARKG(27%) | Factors Impacting IOVA price | IOVA will decline at least -2.32% in a week (0% probabilities). VIXM(-13%) XLP(-11%) BND(-11%) UUP(-10%) EDOC(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.32% (StdDev 4.64%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.45 | 5 Day Moving Average | $7.19(1.53%) | 10 Day Moving Average | $7.19(1.53%) | 20 Day Moving Average | $7.45(-2.01%) | To recent high | -11.4% | To recent low | 30.1% | Market Cap | $1.069b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |